Fig. 3From: Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemiaPrognostic values of STK10 in AML patients, based on TCGA datasets. a Survival curves of OS between the STK10low and STK10high groups. Prognostic values of STK10 had been shown in the subgroup of the patients ≤ 60 years (b), the patients > 60 years (c), the patients with favorable&intermediate cytogenetic risks (d) and the patients with poor cytogenetic risks (e)Back to article page